Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.
Erba, HP; Stadtmauer, EA; Larson, RA; Sievers, EL; Estey, EH; Lowenberg, B; Leopold, LH; Berger, MS; Herbertson, R; Appelbaum, FR
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
44th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date